drugset / Trial / NCT03768349
PSMA and C-11 Choline PET in Patients With Biochemical Recurrence of Prostate Cancer
Non-randomizedParallel-groupOpen-labelDiagnostic
Summary
Imaging and staging of prostate cancer is critical for surgical and treatment planning. In this protocol we will image patients with suspected metastatic prostate cancer using 11C-Choline PET and Gallium-68 labeled HBED-CC PSMA (more commonly called 68Ga-PSMA-11) or F-18 labeled PSMA 1007 in order to demonstrate their utility in detecting prostate cancer.
Timeline
- Start
- 2019-01-03
- Primary completion
- 2021-07-21
- Completion
- 2021-07-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 68Ga-PSMA-11 | Diagnostic / imaging agent | — | — |
| Subject | F-18 PSMA 1007 | Diagnostic / imaging agent | — | — |